Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides

J R Gnarra1, G R Dressler

  • 1Urological Oncology Section, National Cancer Institute, Bethesda, Maryland 20892, USA.

Cancer Research
|September 15, 1995
PubMed

Insights

Pax-2 gene expression is common in renal cell carcinoma (RCC) and is crucial for tumor cell proliferation. Inhibiting Pax-2 may offer a novel therapeutic strategy for treating kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) is the most prevalent adult kidney malignancy.
  • RCC is believed to originate from the proximal tubule epithelium.
  • Pax-2 is essential for renal epithelium development.

Purpose of the Study:

  • To investigate the expression of Pax-2 in renal cell carcinoma.
  • To determine the role of Pax-2 in RCC cell proliferation.
  • To explore Pax-2 as a potential therapeutic target for RCC.

Main Methods:

  • Immunohistochemical staining of primary tumor samples.
  • Analysis of Pax-2 protein and mRNA expression in RCC cell lines.
  • Treatment of RCC cell lines with antisense oligodeoxynucleotides.

Main Results:

  • Pax-2 was expressed in malignant RCC cells, not in surrounding stroma.
  • 73% of human RCC cell lines showed Pax-2 protein and mRNA expression.
  • Antisense oligodeoxynucleotides targeting Pax-2 reduced protein levels and inhibited cell growth.

Conclusions:

  • Pax-2 gene function is vital for RCC cell proliferation.
  • Pax-2 plays a role in both embryonic renal development and RCC progression.
  • Targeting Pax-2 presents a potential novel therapeutic approach for renal cell carcinoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...